As Amgen catches up with leaders in the burgeoning obesity space, it’s underscoring a “platform approach” and shooting for “broad optionality” in the design of its Phase III.
Peter Griffith Speaking at the Bank of America Merrill Lynch Global Healthcare Conference, Amgen CFO Peter Griffith…
Click here to view original post
